 | Date | Title | Topic | Location | Presenter | Presentation |
|---|
 | | | "Tissue-specific regulation of erythropoietin gene expression by GATA transcription factors" | CG-98 | Jorg Bungert, MD | |
| | | Diabetes, Hypertension and Renal Disease: Perspective of a Clinical Trialist
| C1-3 | Larry Hunsicker, MD | |
| | | “IMLNS. New insights into its pathogenesis” | CG-98 | Eduardo Garine, MD | |
| | | | CG-98 | Edward Ross, MD & Greg Wells, MD | |
| | | “Growth hormone in children with chronic renal insufficiency & after kidney transplantation” | 5433 | Richard Fine, MD | |
| | | “Clinical Trial Design in Nephrology: Issues and Perspectives” | C2-33(Teleconference) | Larry Hunsicker, MD | |
| | | Theories of Renal Stone Formation | CG-98 | Ahsan Ejaz, MD | |
| | | “Molecular Insights into Bartter’s, Gitelman’s and Gordon’s Syndromes” | C2-33(Teleconference) | Steven Hebert, MD | |
| | | "Recurrent FSGS post kidney transplant" | 5433 | Richard Fine, MD | |
| | | | 3149 | Nehal Dassani, MD | |
| | | | CG-98 | Rama Thambuganipalle, MD | |
| | | | CG-98 | Rama Thambuganipalle, MD | |
| | | Morbidity and Mortality in CKD: What are the Risk Factors | CG-98 | David Foster, MD | |
| | | "The Actoclampins: An Entirely New Class of
Cytosketletal Molecular Motors"
| CG-98 | Daniel Purich, MD | |
| | | gamma MSH and
salt-sensitive hypertension
| C1-9 | Michael Humphreys, MD | |
| | | | CG-98 | Mark Segal, MD & Ronak Shah, MD | |
| | | Vascular Calcification in End Stage Renal Disease | CG-98 | Cecilia Giachelli, PhD | |
| | | | CG-98 | Karl Womer, MD | |
| | | | CG-98 | Michael Humphreys, MD | |
| | | Colony Stimulating Factor-1: A Therapeutic Target for Renal Inflammation and Lupus | CG-98 | Vicki Rubin-Kelly, PhD | |
| | | Cellular Control of Vascular Calcification | CG-98 | Cecilia Giachelli, PhD | |
| | | | 3149 | Anna Schuler, MD | |
| | | | CG-98 | Anna Schuler, MD | |
| | | | CG-98 | Nehal Dassani, MD & Gregory Wells, MD | |
| | | | CG-98 | Mike Guske | |
| | | Blood pressure regulates renal sodium transport and visa versa: cellular mechanisms | C1-9 | Alicia McDonough PhD | |
| | | Hypertension and Uric acid in African-Americans | CG-98 | T.R. Srinivas, MD | |
| | | | CG-98 | | |
| | | | CG-98 | Amir Kazory, MD | |
| | | Risk Adjustment: Why? How? and Application in Transplant Center Performance Ratings | CG-98 | Jesse Schold | |
| | | The role of renal tubulointerstitial inflammation in the induction and maintenance of salt-sensitive hypertension | C1-9 | Bernardo Rodriguez-iturbe | |
| | | Hypertension Pharmacogenetics | CG-98 | Julie Johnson, MD | |
| | | | CG-98 | | |
| | | | CG-98 | Kourosh Dibadj, MD | |
| | | The renal physiology of pendrin | C1-9 | Susan Wall, MD | |
| | | | CG-98 | Chris Gersch, PhD | |
| | | | CG-98 | | |
| | | | CG-98 | Nehal Dassani, MD | |
| | | Oxidative stress, inflammation, hypertension, and cardiovascular disease | C1-9 | Nick Vaziri, MD | |
| | | | CG-98 | Ulf Meier-Kriesche, MD | |
| | | | CG-98 | | |
| | | | CG-98 | T. R. Srinivas, MD & Rama Thambuganipalle, MD | |
| | | Lupus: The Wolf, The Bean, The Red Dress | CG-98 | Mark Segal, MD | |
| | | Pharmacokinetic Evaluation of Mycophenolate Mof | CG-98 | Giselle Guerra, MD | |
| | | The Nephropathy of Fabry Disease | C2-33 | Barry M. Brenner, MD | |
| | | GFR in normal and compromized pregnancy | CG-98 | Chris Baylis, PhD | |
| | | Heptode Renal Syndrome | CG-98 | J. Robert Cade, MD | |
| | | Etiopathogenic mechanisms of poststreptococcal Glomerulonephritis | CG-98 | Bernardo Rodriguez-iturbe, MD | |
| | | A Paradigm Shift in Nephrology: The Anemia of Kidney Failure | C2-33 | Joe Eschbach, MD | |
| | | | | | |
| | | Immune renal disease are we making progress? | CG-98 | William Couser, MD | |
| | | | CG-98 | Ronak Shah, MD | |
| | | Glomerular gene deilvery systems | CG-98 | Stan Nahman, MD | |
| | | | CG-98 | Kourosh Dibadj, MD | |
| | | Catheter related bacteremia | CG-98 | Udayan Bhatt, MD | |
| | | H.E.L.P. | CG-98 | Edward Ross, MD | |
| | | | CG-98 | Anna Schuler, MD | |
| | | | CG-98 | Michael Gersch, MD | |
| | | | CG-98 | Amir Kazory, MD | |
| | | | CG-98 | Nehal Dassani, MD | |
| | | | CG-98 | Ronak Shah, MD & Rama Thambuganipalle, MD | |
| | | | 3149 | Amir Kazory, MD | |
| | | | CG-98 | Kourosh Dibadj, MD | |
| | | | CG-98 | Amir Kazory, MD & Ronak Shah, MD | |
| | | | | | |
| | | Is there resistance to EPO | CG-98 | Joe Eschbach, MD | |
| | | | CG-98 | Michael Gersch, MD & Rama Thambuganipalle, MD | |
| | | The interacftion of K+ and NH4+ along the collecting duct | CG-98 | Susan Wall, MD | |
| | | | 3149 | Michael Gersch, MD | |
| | | | | | |
| | | | CG-98 | Kourosh Dibadj, MD & Anna Schuler, MD | |
| | | Molecular mechanisms of dyslipidemia in chronic renal failure | CG-98 | Nick Vaziri, MD | |
| | | | 3149 | Kourosh Dibadj, MD & Anna Schuler, MD | |
| | | | CG-98 | Nehal Dassani, MD & Amir Kazory, MD | |
| | | | CG-98 | Nehal Dassani, MD & Kourosh Dibadj, MD | |
| | | "Renal aquaporins & water balance regulation" and
"Patophysiology of renal aquaporins in diseases associated with urinary concentrating defects or water retention" | CG-98 | Soren Nielson & Jorgen Frokiaer | |
| | | Hereditary Kidney Disease | 6120 | Ahsan Ejaz, MD | |
| | | Cases | 6120 | Fellows | |
| | | Acute Renal Failure | 6120 | JogiRaju Tantravahi, MD | |
| | | Treatment & Management of CKD | 6120 | JogiRagu Tantravahi, MD | |
| | | Chronic Glomerulonephritis & Therapy | 6120 | Richard Johnson, MD | |
| | | Treatment & Management of Diabetic Nephropathy | 6120 | Zvi Talor, MD | |
| | | Metabolic Acidosis/RTA | 6120 | David Weiner, MD | |
| | | Metabolic Alkalosis | 6120 | David Weiner, MD | |
| | | Cases | 6120 | Fellows | |
| | | Secondary Hyperparathyroidism | 6120 | Zvi Talor, MD | |
| | | IgA Nephropathy | 6120 | Richard Johnson, MD | |
| | | | CG-98 | Dibadj, MD | |
| | | Orientation/Charting/Compliance | CG-98 | Edward Ross, MD | |
| | | Continuous Therapies - CVVH & CVVHD | CG-98 | Edward Ross, MD | |
| | | Procedures: Renal Biopsy & Catheter Insertion | CG-98 | Mark Segal, MD | |
| | | Induction and Maintenance Immunosuppression after kidney or kidney/pancreas transplantation | CG-98 | Ulf Meier-Kriesche, MD | |
| | | Treatment & Management of Chronic Hypertension, Refractory Hypertension & Hypertensive Emergencies | CG-98 | I. David Weiner, MD | |
| | | Treatment & Management of Acid-Base Disorders & Therapy | CG-98 | I. David Weiner, MD | |
| | | Clinical Pharmacology of Immunosuppressive Drugs | CG-98 | T. R. Srinivas, MD | |
| | | Preoperative Management of Immunosuppressive | CG-98 | Giselle Guerra, M.D. | |
| | | Treatment & Management of Calcium, Magnesium & Phosphorus Disorders | CG-98 | Ahsan Ejaz, M.D. | |
| | | Post Transplant Complications | CG-98 | T. R. Srinivas, MD | |
| | | Diagnosis & Treatment of Chronic Renal Failure after Kidney Transplantation | CG-98 | Ulf Meier-Kriesche, MD | |
| | | Diagnosis & Treatment Vasculitis and Interstitial Nephritis | CG-98 | Richard Johnson, MD | |